AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

12 hedge funds and large institutions have $2.27M invested in Akari Therapeutics in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$87.4K
2
+$45K
3
+$42.3K
4
Renaissance Technologies
Renaissance Technologies
New York
+$32.3K
5
HF
HRT Financial
New York
+$9.71K

Top Sellers

1
-$765K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$808K
2
$782K
3
$262K
4
$155K
5
$90K
6
$52K
7
$45K
8
$37K
9
$21K
10
$11K
11
$5K
12
$3K
13
–